Navigation Links
Diagenode Announces Acquisition of Service Provider NXT-Dx to Complement Epigenetics Assay Services
Date:8/17/2018

Diagenode today announced the acquisition of NXT-Dx, an established epigenetics service provider based in Gent, Belgium. NXT-Dx provides a broad variety of start-to-finish epigenetics services including a number of targeted DNA methylation assays using pyrosequencing or Next-Generation Sequencing and Illumina’s Infinium Methylation EPIC array. These technologies enable a more targeted approach for the screening of DNA methylation biomarkers. In addition, NXT-Dx offers chromatin and mRNA wet-lab and analysis services.

“We are pleased to add NXT-Dx’s expertise to our growing epigenomics services platform,” stated Didier Allaer, CEO of Diagenode. “The services offered by NXT-Dx perfectly complement Diagenode’s current chromatin, RNA, and DNA methylation assay services and will allow researchers to focus both on discovery and validation of epigenetic signatures.” Allaer also added, “Additionally, the targeted DNA methylation analyses that NXT-Dx offers now close the gap between epigenetics and IVD assay development.”

The added NXT-Dx services give researchers access to easier screening of large patient populations to develop and validate DNA methylation signatures and will broaden Diagenode’s role in epigenetic biomarker discovery.

“We are excited to be enhancing Diagenode’s service portfolio via this acquisition of our complementary services,” said Maarten Braspenning, CEO of NXT-Dx. “With the combined expertise, we can now offer full end-to-end services for IVD screening of biomarkers and clinical validation of DNA methylation signatures.”

To learn more about Diagenode’s Epigenomics Assay Services, visit https://www.diagenode.com/en/categories/Services.

Learn more about NXT-Dx at http://www.nxt-dx.com/.

Diagenode:
Diagenode is a leading provider of complete solutions for epigenetics research and sample preparation. The company has developed both shearing solutions for a number of applications as well as a comprehensive approach to gain new insights into epigenetics studies. The company offers innovative DNA and chromatin shearing and automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company’s latest innovations include the industry’s most validated ChIP antibodies, CATS-based RNA sequencing, and epigenetics assay services. For more information about Diagenode, please visit the company’s website at http://www.diagenode.com.

Read the full story at https://www.prweb.com/releases/diagenode_announces_acquisition_of_service_provider_nxt_dx_to_complement_epigenetics_assay_services/prweb15673133.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. ActiGraph Announces New Scientific Affairs and Data Management Division
2. Trivedi Global, Inc. Announces Research by TC Slade on Energy Treated Vitamin D3 Which Shows Significant Benefits for Bone Health
3. Trivedi Global, Inc. Announces Research by Shirley Holmlund on Energy Treated Vitamin D3 Which Shows Significant Benefits for Bone Health
4. Cereius, Inc. Announces $6.75 Million Financing Proceeds to Advance Novel Therapies for Treating Solid Tumor Brain Metastasis
5. AcCELLerated Biologics announces strategic partnership with Exceleron Media.
6. Ram Group Announces Worlds First Full-Body Biometric Authentication Technology
7. NXT-ID Inc. Announces Appointment of Two New Independent Directors to Board
8. 4Dx Announces Preliminary Clinical Trial Data at Prestigious World Lung Imaging Event
9. Aware, Inc. Announces Resignation of co-Chief Executive Officer & Chief Financial Officer
10. Acuant Announces Best-In-Class Data Capture and Multi-Factor Verification Solutions Addressing Rising Identity Fraud in the Digital Economy
11. Securus Announces the Appointment of a Director of Recidivism and Reentry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/12/2019)... ... November 12, 2019 , ... In’Tech Medical SAS ( ... the creation of a Global Regulatory Affairs Department, to support Medical Device companies ... the regulatory element to any Medtech organization is more important than Research & ...
(Date:11/12/2019)... BEND, Ore. (PRWEB) , ... November 12, 2019 ... ... is launching Cross-Channel Spend Optimizer that improves digital advertising performance up to 25% ... Smart Digital Advertising, Cross-Channel Spend Optimizer uses advanced multi-touch attribution (MTA) to predict ...
(Date:11/12/2019)... ... 2019 , ... Atlantic Ultraviolet Corporation (AUV), the premier manufacturer ... their patented automatic and manual wipers the #1 best feature of the ... task required of an ultraviolet water purifier is quartz sleeve cleaning. A fouled ...
Breaking Biology News(10 mins):
(Date:12/4/2019)... Kingdom (PRWEB) , ... December 03, 2019 , ... ... recombinant antibody products and services, today announced a partnership with the Recombinant Antibody ... University of Toronto, and UC San Francisco (UCSF) with a common goal to ...
(Date:12/4/2019)... ... December 04, 2019 , ... Improved Pharma’s analytical methods provide ... Additionally, their PDF Synchrotron methods provide a way to determine the structure of ... regulatory and patent applications.  , The latest developments were recently shared at the ...
(Date:11/27/2019)... ... November 25, 2019 , ... Silony Medical, a ... robotic-assisted and navigated surgery in the UK. The procedure was performed in the ... Dr. Syed Aftab and Dr. Alexander Montgomery. The surgery, which took place on ...
(Date:11/20/2019)... NEWTOWN, Conn. (PRWEB) , ... November 20, 2019 ... ... is projecting worldwide production of about 8,500 microturbine electrical power generation units from ... is a significant increase over 2017's projection of 3,821 units worth $569 million. ...
Breaking Biology Technology: